CYP2A6

gene product
CPA6, CYP2A, CYP2A3
This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
111 antibodies from 16 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Abnova Corporation
6 antibodies
antibodies-online
36 antibodies
OriGene
5 antibodies
LifeSpan BioSciences, Inc.
15 antibodies
Novus Biologicals
5 antibodies
Thermo Fisher Scientific Pierce
4 antibodies
Acris Antibodies GmbH
7 antibodies
Aviva Systems Biology
5 antibodies
RabMAbs
2 antibodies
GeneTex
5 antibodies
Creative Biomart
11 antibodies
Atlas Antibodies
1 antibody
Biorbyt
3 antibodies
Bioworld Technology, Inc
1 antibody
Enzo Life Sciences
4 antibodies
EMD Millipore
1 antibody